We are live on ! Find out more
Invesco

Invesco Portfolio holdings

AUM $1.02T
1-Year Est. Return 30.18%
 

Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.

This Fund
S&P 500
This Quarter Est. Return
+6.43%
1 Year Est. Return
+30.18%
3 Year Est. Return
+96.06%
5 Year Est. Return
+126.45%
10 Year Est. Return
+482.58%
AUM
$318B
AUM Growth
+$15.6B
Cap. Flow
-$1.79B
Cap. Flow %
-0.56%
Top 10 Hldgs %
17.75%
Holding
4,003
New
124
Increased
1,958
Reduced
1,647
Closed
117

Top Buys

Rank Stock Value
1
PEP icon
PepsiCo
PEP
+$1.42B
2
JNJ icon
Johnson & Johnson
JNJ
+$685M
3
SLB icon
SLB Ltd
SLB
+$281M
4
MDLZ icon
Mondelez International
MDLZ
+$241M
5
BABA icon
Alibaba
BABA
+$229M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$377M
2
WBA
Walgreens Boots Alliance
WBA
+$296M
3
AMGN icon
Amgen
AMGN
+$278M
4
GGP
GGP Inc.
GGP
+$250M
5
EA icon
Electronic Arts
EA
+$250M

Sector Composition

Rank Sector Weight
1 Technology 19.74%
2 Financials 13.21%
3 Healthcare 12.3%
4 Consumer Discretionary 11.6%
5 Communication Services 9.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MTNB icon
3726
Matinas BioPharma
MTNB
$1.91M
$21K ﹤0.01%
448
-68
-13% -$1.46K
ALSK
3727
DELISTED
Alaska Communications Systems
ALSK
$20K ﹤0.01%
12,018
-2,079
-15% -$3.59K
AMPE
3728
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$19K ﹤0.01%
122
+28
+30% +$11.7K
ONCS
3729
DELISTED
OncoSec Medical Incorporated
ONCS
$18K ﹤0.01%
+58
New +$17.8K
SNMX
3730
DELISTED
Senomyx, Inc.
SNMX
$17K ﹤0.01%
11,530
-2,716
-19% -$3.19K
CGRN
3731
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
$16K ﹤0.01%
1,627
-246
-13% -$3.14K
IMBI
3732
DELISTED
iMedia Brands, Inc. Class A Common Stock
IMBI
$16K ﹤0.01%
1,428
-216
-13% -$2.84K
CFMS
3733
DELISTED
Conformis, Inc. Common Stock
CFMS
$16K ﹤0.01%
593
-90
-13% -$2.45K
ADXS
3734
DELISTED
Advaxis Inc
ADXS
$15K ﹤0.01%
+1,066
New +$20.8K
UQM
3735
DELISTED
UQM Technologies, Inc.
UQM
$15K ﹤0.01%
11,156
-4,811
-30% -$5.33K
SCYX icon
3736
SCYNEXIS
SCYX
$37.4M
$14K ﹤0.01%
150
-23
-13% -$2.71K
ATXS
3737
DELISTED
Astria Therapeutics
ATXS
$13K ﹤0.01%
+276
New +$12.4K
ALIM
3738
DELISTED
Alimera Sciences
ALIM
$13K ﹤0.01%
897
-136
-13% -$2.07K
MMAT
3739
DELISTED
Meta Materials Inc. Common Stock
MMAT
$13K ﹤0.01%
67
-10
-13% -$2.25K
UAMY icon
3740
United States Antimony
UAMY
$728M
$12K ﹤0.01%
13,533
-2,363
-15% -$1.42K
GNCA
3741
DELISTED
Genocea Biosciences, Inc.
GNCA
$11K ﹤0.01%
1,719
-260
-13% -$1.37K
VGZ icon
3742
Vista Gold
VGZ
$250M
$10K ﹤0.01%
19,500
-9,856
-34% -$5.54K
WYY icon
3743
WidePoint Corp
WYY
$97.4M
$10K ﹤0.01%
2,128
-322
-13% -$1.62K
RGSE
3744
DELISTED
Real Goods Solar, Inc. Class A
RGSE
$10K ﹤0.01%
+26,177
New +$9.76K
CATX icon
3745
Perspective Therapeutics
CATX
$327M
$9K ﹤0.01%
1,725
+100
+6% +$557
ENSV
3746
DELISTED
Enservco Corp.
ENSV
$9K ﹤0.01%
+770
New +$10.2K
NAVB
3747
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$9K ﹤0.01%
1,869
-534
-22% -$2.02K
TMBR
3748
DELISTED
Timber Pharmaceuticals, Inc.
TMBR
$8K ﹤0.01%
3
QCLS
3749
Q/C Technologies Inc
QCLS
$19.7M
0
GPUS
3750
Hyperscale Data Inc
GPUS
$52.9M
0

Similar funds

Invesco's Q3 2018 Portfolio in Review

As of Q3 2018, Invesco held 4,003 positions worth $318B, up 5.2% from $302B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Invesco's Q3 2018 filing shows 124 new, 1,958 increased, 1,647 reduced and 117 closed positions. Its largest new stake was Hanger Inc.: 3,856,471 shares worth $80.3M. The largest sale was Pfizer, an estimated $377M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.

  • Invesco's largest Q3 2018 buy was Hanger Inc.: 3,856,471 shares worth $80.3M.
  • Invesco added most to PepsiCo in Q3 2018, an estimated $1.42B increase.
  • Invesco's biggest Q3 2018 reduction was Pfizer, cutting an estimated $377M.
  • Invesco fully exited GGP Inc. in Q3 2018, selling an estimated $250M.
  • Invesco's ten largest holdings make up 18% of its $318B portfolio in Q3 2018.
  • Invesco opened 124 new positions and closed 117 in Q3 2018.
  • Invesco's portfolio value rose 5.2% quarter-over-quarter to $318B.

Based on Invesco's 13F filing for Q3 2018, filed 14 Nov 2018.